Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes

Raymond Konger, Rama Malaviya, Alice P. Pentland

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

We examined the contribution of specific EP receptors in regulating cell growth. By RT-PCR and northern hybridization, adult human-keratinocytes express mRNA for three PGE2 receptor subtypes associated with cAMP signaling (EP2, EP3, and small amounts of EP4). In actively growing, non-confluent primary keratinocyte cultures, the EP2 and EP4 selective agonists, 11- deoxy PGE1 and I-OH PGE1, caused complete reversal of indomethacin-induced growth inhibition. The EP3/EP2 agonist (misoprostol), and the EP1/EP2 agonist (17-phenyl trinor PGE2), showed less activity. Similar results were obtained with agonist-induced cAMP formation. The ability of exogenous dibutyryl cAMP to completely reverse indomethacin-induced growth inhibition support the conclusion that growth stimulation occurs via an EP2 and/or EP4 receptor-adenylyl cyclase coupled response. In contrast, activation of EP3 receptors by sulprostone, which is virtually devoid of agonist activity at EP2 or EP4 receptors, inhibited bromodeoxyuridine uptake in indomethacin- treated cells up to 30%. Although human EP3 receptor variants have been shown in other cell types to markedly inhibit cAMP formation via a pertussis toxin sensitive mechanism, EP3 receptor activation and presumably growth inhibition was independent of adenylyl cyclase, suggesting activation of other signaling pathways.

Original languageEnglish (US)
Pages (from-to)221-234
Number of pages14
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1401
Issue number2
DOIs
StatePublished - Feb 4 1998
Externally publishedYes

Fingerprint

Receptors, Prostaglandin E, EP3 Subtype
Receptors, Prostaglandin E, EP2 Subtype
Keratinocytes
Indomethacin
Growth
Adenylyl Cyclases
Prostaglandin E Receptors
Misoprostol
Alprostadil
Pertussis Toxin
Bromodeoxyuridine
Dinoprostone
Polymerase Chain Reaction
Messenger RNA

Keywords

  • (Human)
  • Cyclic AMP
  • Keratinocyte
  • Proliferation
  • Prostaglandin E receptor
  • Receptor agonist

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Biophysics

Cite this

Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. / Konger, Raymond; Malaviya, Rama; Pentland, Alice P.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1401, No. 2, 04.02.1998, p. 221-234.

Research output: Contribution to journalArticle

@article{a7584737a85a4d5a9d332352e0cf8d86,
title = "Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes",
abstract = "We examined the contribution of specific EP receptors in regulating cell growth. By RT-PCR and northern hybridization, adult human-keratinocytes express mRNA for three PGE2 receptor subtypes associated with cAMP signaling (EP2, EP3, and small amounts of EP4). In actively growing, non-confluent primary keratinocyte cultures, the EP2 and EP4 selective agonists, 11- deoxy PGE1 and I-OH PGE1, caused complete reversal of indomethacin-induced growth inhibition. The EP3/EP2 agonist (misoprostol), and the EP1/EP2 agonist (17-phenyl trinor PGE2), showed less activity. Similar results were obtained with agonist-induced cAMP formation. The ability of exogenous dibutyryl cAMP to completely reverse indomethacin-induced growth inhibition support the conclusion that growth stimulation occurs via an EP2 and/or EP4 receptor-adenylyl cyclase coupled response. In contrast, activation of EP3 receptors by sulprostone, which is virtually devoid of agonist activity at EP2 or EP4 receptors, inhibited bromodeoxyuridine uptake in indomethacin- treated cells up to 30{\%}. Although human EP3 receptor variants have been shown in other cell types to markedly inhibit cAMP formation via a pertussis toxin sensitive mechanism, EP3 receptor activation and presumably growth inhibition was independent of adenylyl cyclase, suggesting activation of other signaling pathways.",
keywords = "(Human), Cyclic AMP, Keratinocyte, Proliferation, Prostaglandin E receptor, Receptor agonist",
author = "Raymond Konger and Rama Malaviya and Pentland, {Alice P.}",
year = "1998",
month = "2",
day = "4",
doi = "10.1016/S0167-4889(97)00114-6",
language = "English (US)",
volume = "1401",
pages = "221--234",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes

AU - Konger, Raymond

AU - Malaviya, Rama

AU - Pentland, Alice P.

PY - 1998/2/4

Y1 - 1998/2/4

N2 - We examined the contribution of specific EP receptors in regulating cell growth. By RT-PCR and northern hybridization, adult human-keratinocytes express mRNA for three PGE2 receptor subtypes associated with cAMP signaling (EP2, EP3, and small amounts of EP4). In actively growing, non-confluent primary keratinocyte cultures, the EP2 and EP4 selective agonists, 11- deoxy PGE1 and I-OH PGE1, caused complete reversal of indomethacin-induced growth inhibition. The EP3/EP2 agonist (misoprostol), and the EP1/EP2 agonist (17-phenyl trinor PGE2), showed less activity. Similar results were obtained with agonist-induced cAMP formation. The ability of exogenous dibutyryl cAMP to completely reverse indomethacin-induced growth inhibition support the conclusion that growth stimulation occurs via an EP2 and/or EP4 receptor-adenylyl cyclase coupled response. In contrast, activation of EP3 receptors by sulprostone, which is virtually devoid of agonist activity at EP2 or EP4 receptors, inhibited bromodeoxyuridine uptake in indomethacin- treated cells up to 30%. Although human EP3 receptor variants have been shown in other cell types to markedly inhibit cAMP formation via a pertussis toxin sensitive mechanism, EP3 receptor activation and presumably growth inhibition was independent of adenylyl cyclase, suggesting activation of other signaling pathways.

AB - We examined the contribution of specific EP receptors in regulating cell growth. By RT-PCR and northern hybridization, adult human-keratinocytes express mRNA for three PGE2 receptor subtypes associated with cAMP signaling (EP2, EP3, and small amounts of EP4). In actively growing, non-confluent primary keratinocyte cultures, the EP2 and EP4 selective agonists, 11- deoxy PGE1 and I-OH PGE1, caused complete reversal of indomethacin-induced growth inhibition. The EP3/EP2 agonist (misoprostol), and the EP1/EP2 agonist (17-phenyl trinor PGE2), showed less activity. Similar results were obtained with agonist-induced cAMP formation. The ability of exogenous dibutyryl cAMP to completely reverse indomethacin-induced growth inhibition support the conclusion that growth stimulation occurs via an EP2 and/or EP4 receptor-adenylyl cyclase coupled response. In contrast, activation of EP3 receptors by sulprostone, which is virtually devoid of agonist activity at EP2 or EP4 receptors, inhibited bromodeoxyuridine uptake in indomethacin- treated cells up to 30%. Although human EP3 receptor variants have been shown in other cell types to markedly inhibit cAMP formation via a pertussis toxin sensitive mechanism, EP3 receptor activation and presumably growth inhibition was independent of adenylyl cyclase, suggesting activation of other signaling pathways.

KW - (Human)

KW - Cyclic AMP

KW - Keratinocyte

KW - Proliferation

KW - Prostaglandin E receptor

KW - Receptor agonist

UR - http://www.scopus.com/inward/record.url?scp=0032481417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032481417&partnerID=8YFLogxK

U2 - 10.1016/S0167-4889(97)00114-6

DO - 10.1016/S0167-4889(97)00114-6

M3 - Article

C2 - 9531979

AN - SCOPUS:0032481417

VL - 1401

SP - 221

EP - 234

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 2

ER -